LPL Financial
ADMA icon

LPL Financial’s ADMA Biologics ADMA Stock Holding History

LPL Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
159,655
-15,576
-9% -$142K ﹤0.01% 4153
2026
Q1 		$1.58M Sell
175,231
-120,975
-41% -$1.91M ﹤0.01% 3725
2025
Q4 		$5.4M Buy
296,206
+93,425
+46% +$1.57M ﹤0.01% 2470
2025
Q3 		$2.97M Sell
202,781
-12,401
-6% -$213K ﹤0.01% 2956
2025
Q2 		$3.92M Buy
215,182
+104,929
+95% +$2.14M ﹤0.01% 2511
2025
Q1 		$2.19M Buy
110,253
+50,565
+85% +$874K ﹤0.01% 2878
2024
Q4 		$1.02M Sell
59,688
-521
-0.9% -$9.8K ﹤0.01% 3465
2024
Q3 		$1.2M Buy
60,209
+10,663
+22% +$166K ﹤0.01% 3212
2024
Q2 		$554K Buy
49,546
+32,982
+199% +$277K ﹤0.01% 3792
2024
Q1 		$109K Buy
16,564
+4,620
+39% +$25.3K ﹤0.01% 4662
2023
Q4 		$54K Buy
11,944
+71
+0.6% +$263 ﹤0.01% 4644
2023
Q3 		$42.5K Buy
11,873
+637
+6% +$2.45K ﹤0.01% 4536
2023
Q2 		$41.5K Sell
11,236
-11,657
-51% -$43.2K ﹤0.01% 4443
2023
Q1 		$75.8K Buy
22,893
+1,773
+8% +$6.13K ﹤0.01% 4253
2022
Q4 		$81.9K Buy
+21,120
New +$65.1K ﹤0.01% 4208

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

LPL Financial's ADMA Position: Q2 2026 in Review

LPL Financial reduced its ADMA Biologics (ADMA) stake by 8.9% in Q2 2026, selling an estimated $142K and leaving 159,655 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4153.

LPL Financial first reported a position in ADMA in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.4M in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • LPL Financial held 159,655 shares of ADMA Biologics worth $1.34M as of Q2 2026.
  • LPL Financial sold 15,576 ADMA Biologics shares in Q2 2026, an estimated $142K.
  • ADMA Biologics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4153 holding.
  • LPL Financial first reported a position in ADMA Biologics in Q4 2022 and has held it in 15 quarters since.
  • LPL Financial's ADMA Biologics position peaked at $5.4M in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.